This is the audio-only version of DEVICE LOVE Live! #11, originally recorded June 25th, 2020.
Demonstrating "sufficient clinical evidence" is now a clear and enforced requirement for applications under the EU MDR. Additionally, MDR has more explicit requirements to claim equivalency, making it challenging for manufacturers to leverage clinical data generated by other manufactures for similar devices. If you don't have adequate clinical data, what are your options to achieve MDR compliance, especially if you are no longer able to claim equivalency?
In this DEVICE L❤️VE Live! session, our panel will discuss the following and more:
Best practices and novel approaches to fulfilling sufficient clinical evidence requirements, supported by those that have been accepted by notified bodies in audits Since it is also a requirement to disclose risks of the device, we’ll discuss ideas for predicting occurrence rates when disclosing risks when no clinical data is available — specifically, for new products that do not require clinical trials Creative ideas for generating data during the COVID-19 pandemic, especially when faced with expectations of receiving minimal feedback or having low study enrollment Leveraging CERs to meet the “sufficient clinical evidence” requirements
This panel is loaded with former notified body representatives and seasoned R&Q subject matter experts:
Ibim Tariah, PhD, R&Q VP of EU MDR/IVDR Consulting Services (Former BSI Technical Director of Medical Devices through 2019; 21 years at BSI) Ron Sills, R&Q Sr. Principal Specialist (Former TUV Rheinland Lead Auditor through 2019) Jon Gimbel, PhD, R&Q Exec. Director, Regulatory and Quality Consulting Services, and technical leader of R&Q CER/PER team Celeste Maksim, PhD, R&Q Principal Specialist, and post-market surveillance subject matter expert
Lisa Casavant — Cofounder and Chief Strategy Officer, R&Q
R&Q's mission is to improve people's lives by providing industry-leading regulatory and quality consulting and engineering for medical devices, IVDs, and combination products. We help companies bring safe and effective products to market… and keep them there. Our team of 200+ consultants and counting have served over 300 companies around the globe. Subscribe to our blog, view our service offerings, watch free webinars, and more at RQTeam.com.
The and means more.
GLOBAL BOTTOM CTA INSTRUCTIONS:
To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.
Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!